A to Z Summary Results - Patient Decision Aids - Ottawa Hospital Research Institute 

Decision Aid Summary

Title Esclerosis múltiple [Multiple sclerosis]
Audience People diagnosed with multiple sclerosis at any stage of the disease.
Options included Interferon beta-1a.
Peginterferon beta-1a.
Glatiramer acetate.
Dimethyl fumarate.
High activity: Fingolimod, Natalizumab, Alemtuzumab.
Year of last update or review 2019
Format Web, PDF
How to obtain Click here to view the decision aid on the developer website
Developer Montserrat Moharra
Where was it developed? mmoharra@gencat.cat
Agencia de Calidad y Evaluación Sanitarias de Cataluña (AQuAS)
Health condition Multiple Sclerosis
Type of decision aid Treatment
Language English, Spanish, Catalan
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
7 out of 7 criteria to be defined as a patient decision aid
4 out of 8 criteria to lower the risk of making a biased decision
Not applicable: other criteria for decision aids about screening or testing

Last modified: 2019-06-26.